Our Science

Our Cryopreserve Platelet (CLPH-251) Technology

Cryopreserved Platelets (CLPH-511), a sister cellular product utilizing cryopreservation of platelets, is also in Phase 2 clinical trials. This product provides an early commercial entry point for Cellphire by addressing LSP availability challenges for hospitals with cold chain access, with BLA during 2026 to 2028.

As a sister technology with similarities in sourcing and products, CLPH-521 create synergies with the FPH technology family while increasing the likelihood of a commercial footprint over the near to medium term.

Thrombosomes® at Work

This video shows Thrombosomes® (pale green mass) aggregated at the site of a cut and recruiting circulating human platelets (bright green moving particles) to create a clot and stop bleeding.

Want to hear more about our trials and research?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.